Medicine

Prostate cancer screening, primarily via the PSA test, is recommended as an individual decision for men aged 55 to 69. This approach prioritizes “shared decision-making” to weigh the benefit of early detection against the significant risks of overdiagnosis, overtreatment, and potential side effects like urinary incontinence and erectile dysfunction.